Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial
Biotech
Pfizer axes phase 3 sickle cell study, cites recruitment issues
Pfizer has terminated one of two phase 3 trials assessing a monoclonal antibody designed to treat sickle cell disease.
Gabrielle Masson
Mar 26, 2024 5:31pm
NCI launches remote staff pilot to boost trial enrollment
Mar 5, 2024 4:00pm
2023 clinical trial launches drop 15% YOY
Feb 22, 2024 8:00am
Neuralink implants first brain-computer chip in human trial
Jan 30, 2024 10:10am
CRO industry faces heightened expectations in 2024: report
Jan 4, 2024 1:19pm
'The Top Line': The year in biotech
Dec 22, 2023 7:00am